コンテンツへスキップ
Merck

Intracarotid amobarbital procedure for epilepsy surgery.

Epilepsy & behavior : E&B (2010-12-31)
Ashwini Sharan, Yinn Cher Ooi, John Langfitt, Michael R Sperling
要旨

The intracarotid amobarbital procedure (IAP) has been used for more than half a century to determine language dominance and to assess risk for amnesia after anterior temporal lobectomy. However, because of the risk associated with angiography and the development of noninvasive techniques, the need for the IAP when evaluating patients for epilepsy surgery can now be questioned. The purpose of this review is to examine the clinical indications and efficacy of the Wada test in the preoperative evaluation of epilepsy surgery candidates. This article summarizes a debate that took place during the 2009 American Epilepsy Society (AES) annual course.

材料
製品番号
ブランド
製品内容

Supelco
アモバルビタール 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®